Literature DB >> 11770962

Hyperacusis in Williams syndrome.

L B Johnson1, M Comeau, K D Clarke.   

Abstract

OBJECTIVE: To define hyperacusis in audiologic parameters and to further elucidate central and peripheral auditory pathways. DESIGN AND
SETTING: Theories surrounding hyperacusis have always been highly debated. A group of children with Williams syndrome universally complain of hyperacusis. They have highly reproducible behavioural responses to noise and are thus hampered in their social interactions. Loss of inhibitory modulation to efferent sensory input to the cochlea is thought to be a possible mechanism.
METHODS: Nine patients with Williams syndrome received a complete audiologic work-up, including audiogram, speech reception thresholds, acoustic reflexes, impedance, and transient evoked otoacoustic emissions (TEOAEs). MAIN OUTCOME MEASURES: Assessment of the efferent system is done by measuring changes in TEOAEs following stimulation of the contralateral ear.
RESULTS: Three patients had high-frequency sensorineural hearing loss (SNHL) and thus, as expected, absent TEOAEs, indicating cochlear damage. Two had normal hearing and normal TEOAEs. However, four patients had normal hearing with absent TEOAEs.
CONCLUSIONS: These findings are suggestive of cochlear disease and may, in fact, support the hypothesis of outer hair cell modulation by the ipsilateral medial olivocochlear system. Behavioural aspects of the syndrome make audiologic testing difficult. Thus, the diagnosis of SNHL may be hampered if it truly exists. The data show a preponderance of SNHL in the older age groups of our study population. This either reflects previously missed diagnoses or underlying cochlear disease, which may manifest later in life. Thus, this finding blurs the boundary between loudness recruitment and hyperacusis.

Entities:  

Mesh:

Year:  2001        PMID: 11770962     DOI: 10.2310/7070.2001.20811

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  8 in total

1.  Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome.

Authors:  Nozomu Matsumoto; Rei Kitani; Federico Kalinec
Journal:  Commun Integr Biol       Date:  2011-03

2.  Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome.

Authors:  Ovsanna T Leyfer; Janet Woodruff-Borden; Bonita P Klein-Tasman; Johanna S Fricke; Carolyn B Mervis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-09-05       Impact factor: 3.568

3.  Expecting the worst: observations of reactivity to sound in young children with Williams syndrome.

Authors:  Frank J Gallo; Bonita P Klein-Tasman; Michael S Gaffrey; Phillip Curran
Journal:  Res Dev Disabil       Date:  2007-11-26

4.  Hyperacusis in Children with Attention Deficit Hyperactivity Disorder: A Preliminary Study.

Authors:  Massimo Ralli; Maria Romani; Alessio Zodda; Francesca Yoshie Russo; Giancarlo Altissimi; Maria Patrizia Orlando; Maria Gloria Cammeresi; Roberta Penge; Rosaria Turchetta
Journal:  Int J Environ Res Public Health       Date:  2020-04-27       Impact factor: 3.390

5.  Hyperexcitability of the Nucleus Accumbens Is Involved in Noise-Induced Hyperacusis.

Authors:  Yuying Liu; Ana''am Alkharabsheh; Wei Sun
Journal:  Neural Plast       Date:  2020-11-26       Impact factor: 3.599

Review 6.  A Review of the Neurobiological Mechanisms that Distinguish Between Loudness Recruitment and Hyperacusis.

Authors:  Lin Shi; Rui Zhao; Xinxin Li; Wei Sun; Xiuli Liu
Journal:  Med Sci Monit       Date:  2022-04-09

7.  The efferent system or olivocochlear function bundle - fine regulator and protector of hearing perception.

Authors:  Raphael Richard Ciuman
Journal:  Int J Biomed Sci       Date:  2010-12

8.  Human induced pluripotent stem cell derived neurons as a model for Williams-Beuren syndrome.

Authors:  Shahryar Khattak; Elise Brimble; Wenbo Zhang; Kirill Zaslavsky; Emma Strong; P Joel Ross; Jason Hendry; Seema Mital; Michael W Salter; Lucy R Osborne; James Ellis
Journal:  Mol Brain       Date:  2015-11-24       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.